Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease

ABSTRACT: The current outbreak of the highly transmittable and life-threatening severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved rapidly and posed a global health emergency. Many clinical trials are now being conducted to test possible therapies. To assist this, virtual scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussien, Mostafa A., Abdelaziz, Ahmed E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413836/
https://www.ncbi.nlm.nih.gov/pubmed/32834922
http://dx.doi.org/10.1007/s13721-020-00263-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413836/
https://www.ncbi.nlm.nih.gov/pubmed/32834922
http://dx.doi.org/10.1007/s13721-020-00263-6

Ejemplares similares